AstraZeneca Halts COVID-19 Vaccine Study Over Safety Concerns
Video Credit: CBS 2 Chicago - Duration: 00:18s - Published
AstraZeneca Halts COVID-19 Vaccine Study Over Safety Concerns
A potential COVID-19 vaccine produced by AstraZeneca was one of two being tested in Chicago, but now, the company has put a temporary hold on its large-scale Phase III trial.
The Tucson portion of Moderna's COVID-19 vaccine trail took an important step this week. Blood from participants is now being checked for antibodies, after they received both injections.
Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,..